About Tom Baker Cancer Centre - Holy Cross Site
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
University of Calgary
1
Clinical Trials at Tom Baker Cancer Centre - Holy Cross Site
During the past decade, Tom Baker Cancer Centre - Holy Cross Site conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
2009-09-30
2017-11-02
Completed
1,199
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
2010-09-16
2019-02-14
Completed
1,717
A Comparison of MBSR and CBT for the Treatment of Insomnia in Cancer
2008-09-01
2012-07-01
Completed
111
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tom Baker Cancer Centre - Holy Cross Site"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Canadian Cancer Society (CCS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Tom Baker Cancer Centre - Holy Cross Site
According to Clinical.Site data, the most researched conditions in "Tom Baker Cancer Centre - Holy Cross Site" are
"Cancer" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials), "Insomnia" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Tom Baker Cancer Centre - Holy Cross Site" in a lesser frequency.
Clinical Trials Intervention Types at Tom Baker Cancer Centre - Holy Cross Site
Most popular intervention types in "Tom Baker Cancer Centre - Holy Cross Site" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials), "Placebo" (2 trials), "Cognitive Behavior Therapy" (1 trials) and "Mindfulness-Based Stress Reduction" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tom Baker Cancer Centre - Holy Cross Site
The vast majority of trials in "Tom Baker Cancer Centre - Holy Cross Site" are
2 trials for "Male" genders and 1 trials for "All" genders.
Clinical Trials Status at Tom Baker Cancer Centre - Holy Cross Site
Currently, there are NaN active trials in "Tom Baker Cancer Centre - Holy Cross Site".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Tom Baker Cancer Centre - Holy Cross Site,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tom Baker Cancer Centre - Holy Cross Site, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".